{"id":"https://openalex.org/W4296793845","doi":"https://doi.org/10.1097/cad.0000000000001342","title":"Response to trametinib in a nonsmall cell lung cancer patient with osimertinib resistance harboring GNAS R201C and R201H mutations: a case report","display_name":"Response to trametinib in a nonsmall cell lung cancer patient with osimertinib resistance harboring GNAS R201C and R201H mutations: a case report","publication_year":2022,"publication_date":"2022-08-09","ids":{"openalex":"https://openalex.org/W4296793845","doi":"https://doi.org/10.1097/cad.0000000000001342","pmid":"https://pubmed.ncbi.nlm.nih.gov/35946511","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9481290"},"language":"en","primary_location":{"id":"doi:10.1097/cad.0000000000001342","doi":"https://doi.org/10.1097/cad.0000000000001342","is_oa":true,"landing_page_url":"https://doi.org/10.1097/cad.0000000000001342","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1097/cad.0000000000001342","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100296800","display_name":"You Lv","orcid":"https://orcid.org/0000-0003-4023-2634","observed_orcids":["https://orcid.org/0000-0003-4023-2634"]},"institutions":[{"id":"https://openalex.org/I4210099558","display_name":"Shanghai Changzheng Hospital","ror":"https://ror.org/0103dxn66","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210099558"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"You Lv","raw_affiliation_strings":["Changzheng Hospital, Navy Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Changzheng Hospital, Navy Medical University","institution_ids":["https://openalex.org/I4210099558"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100754452","display_name":"Chao Zhou","orcid":"https://orcid.org/0000-0003-4942-8422","observed_orcids":["https://orcid.org/0000-0003-4942-8422"]},"institutions":[{"id":"https://openalex.org/I177933477","display_name":"Second Military Medical University","ror":"https://ror.org/04tavpn47","country_code":"CN","type":"education","lineage":["https://openalex.org/I177933477"]},{"id":"https://openalex.org/I4210099558","display_name":"Shanghai Changzheng Hospital","ror":"https://ror.org/0103dxn66","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210099558"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chao Zhou","raw_affiliation_strings":["Department of Pulmonary and Critical Care Medicine, Changzheng Hospital, Navy Medical University, Shanghai"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pulmonary and Critical Care Medicine, Changzheng Hospital, Navy Medical University, Shanghai","institution_ids":["https://openalex.org/I177933477","https://openalex.org/I4210099558"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103798333","display_name":"Zhonghai Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhonghai Chen","raw_affiliation_strings":["Jiaxing Key Laboratory of Precision Medicine and Companion Diagnostics, Jiaxing Yunying Medical Inspection Co., Ltd., Jiaxing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiaxing Key Laboratory of Precision Medicine and Companion Diagnostics, Jiaxing Yunying Medical Inspection Co., Ltd., Jiaxing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012323428","display_name":"Xiaokai Zhao","orcid":"https://orcid.org/0000-0001-8359-5406","observed_orcids":["https://orcid.org/0000-0001-8359-5406","https://orcid.org/0000-0002-8975-9499"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaokai Zhao","raw_affiliation_strings":["Jiaxing Key Laboratory of Precision Medicine and Companion Diagnostics, Jiaxing Yunying Medical Inspection Co., Ltd., Jiaxing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiaxing Key Laboratory of Precision Medicine and Companion Diagnostics, Jiaxing Yunying Medical Inspection Co., Ltd., Jiaxing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100411563","display_name":"Yonghua Sun","orcid":"https://orcid.org/0000-0001-9368-6969","observed_orcids":["https://orcid.org/0000-0001-9368-6969"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yonghua Sun","raw_affiliation_strings":["Jiaxing Key Laboratory of Precision Medicine and Companion Diagnostics, Jiaxing Yunying Medical Inspection Co., Ltd., Jiaxing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiaxing Key Laboratory of Precision Medicine and Companion Diagnostics, Jiaxing Yunying Medical Inspection Co., Ltd., Jiaxing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jieyi Li","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jieyi Li","raw_affiliation_strings":["Jiaxing Key Laboratory of Precision Medicine and Companion Diagnostics, Jiaxing Yunying Medical Inspection Co., Ltd., Jiaxing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiaxing Key Laboratory of Precision Medicine and Companion Diagnostics, Jiaxing Yunying Medical Inspection Co., Ltd., Jiaxing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113098739","display_name":"Ziying Gong","orcid":"https://orcid.org/0000-0003-2619-6446","observed_orcids":["https://orcid.org/0000-0003-2619-6446"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ziying Gong","raw_affiliation_strings":["Jiaxing Key Laboratory of Precision Medicine and Companion Diagnostics, Jiaxing Yunying Medical Inspection Co., Ltd., Jiaxing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiaxing Key Laboratory of Precision Medicine and Companion Diagnostics, Jiaxing Yunying Medical Inspection Co., Ltd., Jiaxing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Daoyun Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Daoyun Zhang","raw_affiliation_strings":["Jiaxing Key Laboratory of Precision Medicine and Companion Diagnostics, Jiaxing Yunying Medical Inspection Co., Ltd., Jiaxing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiaxing Key Laboratory of Precision Medicine and Companion Diagnostics, Jiaxing Yunying Medical Inspection Co., Ltd., Jiaxing, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027184005","display_name":"Hai Yan Huang","orcid":"https://orcid.org/0000-0002-6928-3198","observed_orcids":["https://orcid.org/0000-0002-6928-3198","https://orcid.org/0000-0001-9841-1147","https://orcid.org/0009-0006-9877-2755"]},"institutions":[{"id":"https://openalex.org/I177933477","display_name":"Second Military Medical University","ror":"https://ror.org/04tavpn47","country_code":"CN","type":"education","lineage":["https://openalex.org/I177933477"]},{"id":"https://openalex.org/I4210099558","display_name":"Shanghai Changzheng Hospital","ror":"https://ror.org/0103dxn66","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210099558"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hai Huang","raw_affiliation_strings":["Department of Pulmonary and Critical Care Medicine, Changzheng Hospital, Navy Medical University, Shanghai","to Hai Huang, PhD, Department of Pulmonary and Critical Care Medicine, Changzheng Hospital, Navy Medical University, 415 Fengyang Road, Shanghai, 200003, China Tel: +86 21 81885325"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pulmonary and Critical Care Medicine, Changzheng Hospital, Navy Medical University, Shanghai","institution_ids":["https://openalex.org/I177933477","https://openalex.org/I4210099558"]},{"raw_affiliation_string":"to Hai Huang, PhD, Department of Pulmonary and Critical Care Medicine, Changzheng Hospital, Navy Medical University, 415 Fengyang Road, Shanghai, 200003, China Tel: +86 21 81885325","institution_ids":["https://openalex.org/I4210099558"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6448,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.68280742,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"33","issue":"9","first_page":"966","last_page":"969"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trametinib","display_name":"trametinib","score":0.9449999928474426},{"id":"https://openalex.org/keywords/osimertinib-resistance","display_name":"osimertinib resistance","score":0.9919999837875366},{"id":"https://openalex.org/keywords/gnas-mutation","display_name":"GNAS mutation","score":0.890999972820282},{"id":"https://openalex.org/keywords/egfr-l858r-mutation","display_name":"L858R mutation","score":0.8399999737739563},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9049999713897705},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.9580000042915344},{"id":"https://openalex.org/keywords/egfr-tki-resistance","display_name":"EGFR tyrosine kinase inhibitor resistance","score":0.8489999771118164},{"id":"https://openalex.org/keywords/mapk-inhibitors","display_name":"MAPK inhibitors","score":0.39399999380111694},{"id":"https://openalex.org/keywords/icotinib","display_name":"icotinib","score":0.7110000252723694},{"id":"https://openalex.org/keywords/acquired-resistance-mutations","display_name":"acquired resistance mutations","score":0.4659999907016754}],"concepts":[{"id":"https://openalex.org/C2777626846","wikidata":"https://www.wikidata.org/wiki/Q21506464","display_name":"Osimertinib","level":5,"score":0.9811211824417114},{"id":"https://openalex.org/C74231797","wikidata":"https://www.wikidata.org/wiki/Q14905160","display_name":"GNAS complex locus","level":3,"score":0.9100182056427002},{"id":"https://openalex.org/C2778472372","wikidata":"https://www.wikidata.org/wiki/Q7833138","display_name":"Trametinib","level":4,"score":0.7869918942451477},{"id":"https://openalex.org/C2777930144","wikidata":"https://www.wikidata.org/wiki/Q25100112","display_name":"T790M","level":5,"score":0.735650897026062},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.68079674243927},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5818080902099609},{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.5785316228866577},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5555395483970642},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47054749727249146},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4436376094818115},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.4268583655357361},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.40707212686538696},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.26913177967071533},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.21172592043876648},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.16294261813163757},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1492094099521637},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.1301073133945465},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.10930085182189941},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0867982804775238},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0843043327331543},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000178","descriptor_name":"Acrylamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000814","descriptor_name":"Aniline Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D002864","descriptor_name":"Chromogranins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002864","descriptor_name":"Chromogranins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019205","descriptor_name":"GTP-Binding Protein alpha Subunits, Gs","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019205","descriptor_name":"GTP-Binding Protein alpha Subunits, Gs","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/cad.0000000000001342","doi":"https://doi.org/10.1097/cad.0000000000001342","is_oa":true,"landing_page_url":"https://doi.org/10.1097/cad.0000000000001342","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9481290","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9481290","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer Drugs","raw_type":"Text"},{"id":"pmid:35946511","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35946511","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.1097/cad.0000000000001342","doi":"https://doi.org/10.1097/cad.0000000000001342","is_oa":true,"landing_page_url":"https://doi.org/10.1097/cad.0000000000001342","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W2039094079","https://openalex.org/W2101878300","https://openalex.org/W2138162490","https://openalex.org/W2691505782","https://openalex.org/W2809980410","https://openalex.org/W2945638570","https://openalex.org/W2999801017","https://openalex.org/W3005468694","https://openalex.org/W3043250176","https://openalex.org/W3130734661"],"related_works":["https://openalex.org/W4311677159","https://openalex.org/W4399142341","https://openalex.org/W4283310759","https://openalex.org/W2790922923","https://openalex.org/W2976334328","https://openalex.org/W4296608949","https://openalex.org/W4407240505","https://openalex.org/W4289857161","https://openalex.org/W3087624390","https://openalex.org/W3194519674"],"abstract_inverted_index":{"Osimertinib,":[0],"an":[1],"orally":[2],"administered":[3],"third-generation":[4],"epidermal":[5],"growth":[6],"factor":[7],"receptor":[8],"(EGFR)":[9],"tyrosine":[10],"kinase":[11],"inhibitor,":[12],"is":[13],"widely":[14],"approved":[15],"for":[16,66],"the":[17,32,39,94,126,135,139],"first-line":[18],"and":[19,57,90,92,102,111,133,144],"second-line":[20],"treatment":[21,41,162],"of":[22,35,138,141],"advanced":[23],"non-small-cell":[24],"lung":[25,78],"cancer":[26],"(NSCLC)":[27],"with":[28,44,76,109],"EGFR":[29,45,81,95,130],"mutations.":[30,170],"However,":[31],"rapid":[33],"development":[34],"osimertinib":[36,50,127],"resistance":[37,59,128],"renders":[38],"unsustainable":[40],"benefit.":[42],"Patients":[43],"-mutated":[46],"NSCLC":[47,148,165],"who":[48,84],"develop":[49],"resistance,":[51],"especially":[52],"those":[53],"acquiring":[54],"relatively":[55],"rare":[56],"'off-target'":[58],"mutations,":[60],"still":[61],"lack":[62],"effective":[63],"therapeutic":[64],"options":[65],"postosimertinib":[67],"therapy.":[68],"Herein,":[69],"we":[70],"reported":[71],"a":[72,161],"73-year-old":[73],"woman":[74],"diagnosed":[75],"T1N3M1":[77],"adenocarcinoma":[79],"harboring":[80,167],"L858R":[82,96],"mutation,":[83],"acquired":[85],"two":[86],"GNAS":[87,122,142,168],"mutations":[88],"(R201C":[89],"R201H)":[91],"lost":[93],"mutation":[97],"after":[98],"progression":[99],"on":[100],"icotinib":[101],"osimertinib.":[103],"The":[104],"patient":[105],"was":[106,113],"subsequently":[107],"treated":[108],"trametinib":[110,152,158],"there":[112],"no":[114],"obvious":[115],"tumor":[116],"increase.":[117],"Our":[118,154],"study":[119],"revealed":[120],"that":[121,157],"R201":[123],"can":[124],"confer":[125],"in":[129,147,164],"-positive":[131],"NSCLC,":[132],"present":[134],"first":[136],"report":[137],"prevalence":[140],"R201C":[143],"R201H":[145],"mutants":[146],"which":[149],"response":[150],"to":[151],"treatment.":[153],"case":[155],"suggests":[156],"could":[159],"be":[160],"option":[163],"patients":[166],"-activating":[169]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-09-24T00:00:00"}